Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
Current Oncology (Toronto, Ont.)
|
September 26, 2025
Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications
Servando Hernandez Vargas, Solmaz Aghaamiri, Jack T Adams, et al.
EMBO Molecular Medicine
|
June 17, 2024
DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer
Majid Momeny, Mari Tienhaara, Mukund Sharma, et al.
Neurotoxicology
|
March 19, 2018
Maternal exposure to silver nanoparticles are associated with behavioral abnormalities in adulthood: Role of mitochondria and innate immunity in developmental toxicity
Shayan Amiri, Aliakbar Yousefi-Ahmadipour, Mir-Jamal Hosseini, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 6, 2017
Oxytocin mitigated the depressive-like behaviors of maternal separation stress through modulating mitochondrial function and neuroinflammation
Hossein Amini-Khoei, Ali Mohammadi-Asl, Shayan Amiri, et al.
European Journal of Pharmacology
|
June 29, 2020
Cediranib, an inhibitor of vascular endothelial growth factor receptor kinases, inhibits proliferation and invasion of prostate adenocarcinoma cells
Majid Momeny, Ghazaleh Sankanian, Sepideh Hamzehlou, et al.
Tumori
|
July 20, 2018
IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer
Hassan Yousefi, Majid Momeny, Seyed H Ghaffari, et al.
Oncotarget
|
February 11, 2015
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines
Majid Momeny, Jodi M Saunus, Flavia Marturana, et al.
Anti-Cancer Drugs
|
August 11, 2018
Inhibition of bromodomain and extraterminal domain reduces growth and invasive characteristics of chemoresistant ovarian carcinoma cells
Majid Momeny, Haniyeh Eyvani, Farinaz Barghi, et al.
Science Translational Medicine
|
July 20, 2018
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells
Otto Kauko, Caitlin M O'Connor, Evgeny Kulesskiy, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
April 27, 2019
The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells
Majid Momeny, Fatemeh Esmaeili, Sepideh Hamzehlou, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
Current Oncology (Toronto, Ont.)
|
September 26, 2025
Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications
Servando Hernandez Vargas, Solmaz Aghaamiri, Jack T Adams, et al.
EMBO Molecular Medicine
|
June 17, 2024
DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer
Majid Momeny, Mari Tienhaara, Mukund Sharma, et al.
Neurotoxicology
|
March 19, 2018
Maternal exposure to silver nanoparticles are associated with behavioral abnormalities in adulthood: Role of mitochondria and innate immunity in developmental toxicity
Shayan Amiri, Aliakbar Yousefi-Ahmadipour, Mir-Jamal Hosseini, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
March 6, 2017
Oxytocin mitigated the depressive-like behaviors of maternal separation stress through modulating mitochondrial function and neuroinflammation
Hossein Amini-Khoei, Ali Mohammadi-Asl, Shayan Amiri, et al.
European Journal of Pharmacology
|
June 29, 2020
Cediranib, an inhibitor of vascular endothelial growth factor receptor kinases, inhibits proliferation and invasion of prostate adenocarcinoma cells
Majid Momeny, Ghazaleh Sankanian, Sepideh Hamzehlou, et al.
Tumori
|
July 20, 2018
IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer
Hassan Yousefi, Majid Momeny, Seyed H Ghaffari, et al.
Oncotarget
|
February 11, 2015
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines
Majid Momeny, Jodi M Saunus, Flavia Marturana, et al.
Anti-Cancer Drugs
|
August 11, 2018
Inhibition of bromodomain and extraterminal domain reduces growth and invasive characteristics of chemoresistant ovarian carcinoma cells
Majid Momeny, Haniyeh Eyvani, Farinaz Barghi, et al.
Science Translational Medicine
|
July 20, 2018
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells
Otto Kauko, Caitlin M O'Connor, Evgeny Kulesskiy, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
April 27, 2019
The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells
Majid Momeny, Fatemeh Esmaeili, Sepideh Hamzehlou, et al.
Page
of 9